Search results (311)
Sex and gender-sensitive medicine: are we ready to switch paradigm?
Examining sex- and gender-related differences may potentially be the new frontier in the era of precision medicine to tailor cancer treatments in men and women.
Ceritinib demonstrates efficacy in brain metastases in ALK+ NSCLC
Results from ASCEND-7 trial confirms the place of ceritinib as a standard treatment option for patients with ALK+ non-small-cell lung cancer and active brain metastases
Over one hundred ESMO research fellows in 30 years
2019 marks the 30th Anniversary of the ESMO Fellowship Programme, a programme that has provided many young oncologists valuable educational opportunities, shaped professional lives and enhanced careers